Epstein-barr virus-associated lymphoproliferative disorder in crohn disease treated with azathioprine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 2, 2010, Pages 229-231

  Ross, Sherina ^a   Rajwal, Sanjay Kumar ^a   Sugarman, Ian ^b   Picton, Susan ^c   Devlin, James ^d   Davison, Suzanne ^a   McClean, Patricia ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b Department of Paediatric Surgery ^*  (Australia)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; GANCICLOVIR; MESALAZINE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL PAIN; ADD ON THERAPY; ARTICLE; CASE REPORT; CERVICAL LYMPH NODE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DUODENITIS; ENDOSCOPY; EPSTEIN BARR VIRUS; FEVER; HEPATOSPLENOMEGALY; HUMAN; ILEITIS; JAUNDICE; LIVER FAILURE; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; MALE; MULTIPLE CYCLE TREATMENT; NUTRITIONAL SUPPORT; ORAL BIOPSY; PANCYTOPENIA; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REMISSION; SCHOOL CHILD; SWELLING; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VIRUS INFECTION;

AZATHIOPRINE; B-LYMPHOCYTES; CHILD; CROHN DISEASE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPROLIFERATIVE DISORDERS; MALE;

HUMAN HERPESVIRUS 4;

EID: 77955231283     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181d893c6     Document Type: Article

References (16)

1. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-1233
2. Gillen CD, Andrews HA, Prior P, et al. Crohn's disease and colorectal cancer. Gut 1994;35:651-655
3. Farrell RJ, Ang Y, Kileen P, et al. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall incidence is low. Gut 2000;47:514-519
4. Korelitz BI, Mirsky FJ, Fleisher MR, et al. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 1999;94:3248-3253
5. Cucchiara S, Escher JC, Hildebrand H, et al. Pediatric inflammatory bowel disease and the risk of lymphoma: should we revise our treatment strategies? J Pediatr Gastroenterol Nutr 2009;48:257-267
6. Dayharsh GA, Loftus EV Jr, Sandborn WJ, et al. Epstein-Barr virus positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 2002;122: 72-77
7. Pearson DC, May GR, Fick G, Sutherland LR. Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev 2000;(2):CD000067.
8. N'guyen Y, Andreoletti L, Patey M, et al. Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease. J Clin Microbiol 2009;47:1252-1254
9. Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. Transplantation 1999;68: 1517-1525
10. Tao J, Wasik MA. Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings. Lab Invest 2001;81:429-437
11. Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005;54:1121-1125
12. Lewis DL, Schwartz JS, Lichtenstein GR. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 2000;118:1018-1024
13. Masunaga Y, Ohno K, Ogawa R, et al. Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother 2007;41:21-28
14. Larvol L, Soule JC, Le Tourneau A. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. N Engl J Med 1994;331: 883-884
15. Kumar S, Fend F, Quintanilla-Martinez L, et al. Epstein-Barr virus positive primary gastrointestinal Hodgkin's disease. Am J Surg Pathol 2000;24:66-73.
16. Li S, Borowitz MJ. Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn's disease. Arch Pathol Lab Med 2001;125:424-427